Loss of p16 expression, mostly an epigenetic suppression mediated by methylation, has been described, well before the demonstration of HPV-driven carcinogenesis, to be a frequent molecular abnormality in HNSCC [18,52,53] with a negative prognostic impact in LSCC [31]. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.